Researchers Find Serious Cybersecurity Vulnerabilities In Siemens Operating System Software: Report

Researchers have shared details about cybersecurity vulnerabilities with Siemens software with CNN and are working with the company to mitigate the risk.

Siemens Healthineers name on its offices in Issaquah, WA

Researchers have found a cybersecurity vulnerability in a Siemens software used by a slew of medical devices. According to a report by CNN, the researchers, Siemens and federal agencies worked together to mitigate the threat, and so far no one has been adversely affected.

The cybersecurity firms Forescout Technologies and Medigate informed CNN that some versions of Siemens’ Nucleus Real-time Operating System (RTOS) could be vulnerable to malicious hackers. According to the researchers, about...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.